Decreased expression of microRNA-200b is an independent unfavorable prognostic factor for glioma patients

Cancer Epidemiology

Volumn 38, Issue 2, 2014, Pages 152-156

  Men, Donghai ^a   Liang, Yuansheng ^a   Chen, Liyi ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Glioma; MicroRNA 200b; Prognosis; Real time quantitative RT PCR assay

Indexed keywords

MICRORNA 200B; MICRORNA; MIRN200 MICRORNA, HUMAN;

ADULT; ARTICLE; BRAIN TISSUE; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; FEMALE; FOLLOW UP; GENE EXPRESSION; GLIOMA; HUMAN; HUMAN TISSUE; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; AGED; BIOSYNTHESIS; BRAIN TUMOR; GENETICS; METABOLISM; PROGNOSIS; SURVIVAL RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE;

EID: 84898021452     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2014.01.003     Document Type: Article

References (38)

1. Wang Y., Jiang T. Understanding high grade glioma: molecular mechanism, therapy and comprehensive management. Cancer Lett 2013, 331:139-146.
2. McCarthy B.J., Shibui S., Kayama T., Miyaoka E., Narita Y., Murakami M., et al. Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registries. Neuro Oncol 2012, 14:1194-1200.
3. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., Jouvet A., et al. The 2007 WHO classification of tumors of the central nervous system. Acta Neuropathol 2007, 114:97-109.
4. Zhang X., Yang H., Gong B., Jiang C., Yang L. Combined gene expression and protein interaction analysis of dynamic modularity in glioma prognosis. J Neurooncol 2012, 107:281-288.
5. Chu S.H., Ma Y.B., Feng D.F., Zhang H., Zhu Z.A., Li Z.Q., et al. Correlation of low SLC22A18 expression with poor prognosis in patients with glioma. J Clin Neurosci 2012, 19:95-98.
6. Pillai R.S. MicroRNA function: multiple mechanisms for a tiny RNA. RNA 2005, 11:1753-1761.
7. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
8. Ling H., Zhang W., Calin G.A. Principles of microRNA involvement in human cancers. Chin J Cancer 2011, 11:739-748.
9. Gao H., Zhao H., Xiang W. Expression level of human miR-34a correlates with glioma grade and prognosis. J Neurooncol 2013, 113:221-228.
10. He J., Deng Y., Yang G., Xie W. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma. J Surg Oncol 2013, 108:121-125.
11. He Z., Cen D., Luo X., Li D., Li P., Liang L., et al. Downregulation of miR-383 promotes glioma cell invasion by targeting insulin-like growth factor 1 receptor. Med Oncol 2013, 30:557.
12. Lee H.K., Bier A., Cazacu S., Finniss S., Xiang C., Twito H., et al. MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor. PLoS ONE 2013, 8:e54652.
13. Wang S., Lu S., Geng S., Ma S., Liang Z., Jiao B. Expression and clinical significance of microRNA-326 in human glioma miR-326 expression in glioma. Med Oncol 2013, 30:373.
14. Chang C., Shi H., Wang C., Wang J., Geng N., Jiang X., et al. Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma. Neurosci Lett 2012, 531:204-208.
15. Sun B., Pu B., Chu D., Chu X., Li W., Wei D. MicroRNA-650 expression in glioma is associated with prognosis of patients. J Neurooncol 2013, 115:375-380.
16. Li G., Zhang Z., Tu Y., Jin T., Liang H., Cui G., et al. Correlation of microRNA-372 upregulation with poor prognosis in human glioma. Diagn Pathol 2013, 8:1.
17. Lu S., Wang S., Geng S., Ma S., Liang Z., Jiao B. Increased expression of microRNA-17 predicts poor prognosis in human glioma. J Biomed Biotechnol 2012, 2012:970761.
18. Zhang C., Zhang J., Hao J., Shi Z., Wang Y., Han L., et al. High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma. J Transl Med 2012, 10:119.
19. Jiang J., Sun X., Wang W., Jin X., Bo X., Li Z., et al. Tumor microRNA-335 expression is associated with poor prognosis in human glioma. Med Oncol 2012, 29:3472-3477.
20. Park S.M., Gaur A.B., Lengyel E., Peter M.E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008, 22:894-907.
21. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., Farshid G., et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008, 10:593-601.
22. Pecot C.V., Rupaimoole R., Yang D., Akbani R., Ivan C., Lu C., et al. Tumour angiogenesis regulation by the miR-200 family. Nat Commun 2013, 4:2427.
23. Toiyama Y., Hur K., Tanaka K., Inoue Y., Kusunoki M., Boland C.R., et al. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer. Ann Surg 2013, [in press].
24. Zhang H.F., Xu L.Y., Li E.M. A family of pleiotropically acting microRNAs in cancer progression, miR-200: potential cancer therapeutic targets. Curr Pharm Des 2013, [in press].
25. Xu S., Xu P., Wu W., Ou Y., Xu J., Zhang G., et al. The biphasic expression pattern of miR-200a and E-cadherin in epithelial ovarian cancer and its correlation with clinicopathological features. Curr Pharm Des 2013, [in press].
26. Pacurari M., Addison J.B., Bondalapati N., Wan Y.W., Luo D., Qian Y., et al. The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells. Int J Oncol 2013, 43:548-560.
27. Siebzehnrubl F.A., Silver D.J., Tugertimur B., Deleyrolle L.P., Siebzehnrubl D., Sarkisian M.R., et al. The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance. EMBO Mol Med 2013, 5:1196-1212.
28. Feng B., Wang R., Chen L.B. Review of miR-200b and cancer chemosensitivity. Biomed Pharmacother 2012, 66:397-402.
29. Köhler C.U., Bryk O., Meier S., Lang K., Rozynek P., Brüning T., et al. Analyses in human urothelial cells identify methylation of miR-152, miR-200b and miR-10a genes as candidate bladder cancer biomarkers. Biochem Biophys Res Commun 2013, 438:48-53.
30. Peng B., Hu S., Jun Q., Luo D., Zhang X., Zhao H., et al. MicroRNA-200b targets CREB1 and suppresses cell growth in human malignant glioma. Mol Cell Biochem 2013, 379:51-58.
31. Chuang J.C., Jones P.A. Epigenetics and microRNAs. Pediatr Res 2007, 61:24R-29R.
32. Vrba L., Jensen T.J., Garbe J.C., Heimark R.L., Cress A.E., Dickinson S., et al. Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells. PLoS ONE 2010, 5:e8697.
33. Iorio M.V., Visone R., Di Leva G., Donati V., Petrocca F., Casalini P., et al. MicroRNA signatures in human ovarian cancer. Cancer Res 2007, 67:8699-8707.
34. Korpal M., Lee E.S., Hu G., Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 2008, 283:14910-14914.
35. Manavalan T.T., Teng Y., Litchfield L.M., Muluhngwi P., Al-Rayyan N., Klinge C.M. Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cells. PLoS ONE 2013, 8:e62334.
36. Feng B., Wang R., Song H.Z., Chen L.B. MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3. Cancer 2012, 118:3365-3376.
37. Tang H., Deng M., Tang Y., Xie X., Guo J., Kong Y., et al. miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression. Clin Cancer Res 2013, 19:5602-5612.
38. Kurashige J., Kamohara H., Watanabe M., Hiyoshi Y., Iwatsuki M., Tanaka Y., et al. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. Ann Surg Oncol 2012, 19:S656-S664.